Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Revenue

Apex Biotechnology had revenue of 470.65M TWD in the quarter ending June 30, 2026, a decrease of -7.71%. This brings the company's total for the last twelve months to 1.87B, down -8.15% year-over-year. In the year 2025, Apex Biotechnology had annual revenue of 1.94B with 5.00% growth. That makes Apex Biotechnology the 26,963rd largest company in the world by revenue and 1,243rd in Taiwan.

• Revenue (ttm): 1.87B
• Revenue Growth: -8.15%
• P/S Ratio: 1.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.90B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 885.18M 45.5%
• Italy 535.58M 27.5%
• Austria 276.07M 14.2%
• Others 149.16M 7.7%
• Taiwan 75.86M 3.9%
• Mainland China 23.06M 1.2%

Fiscal year ended Dec 31, 2025 See the full Apex Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.94B	92.70M	5.00%
Dec 31, 2024	1.85B	175.67M	10.48%
Dec 31, 2023	1.68B	-567.64M	-25.29%
Dec 31, 2022	2.24B	112.52M	5.28%
Dec 31, 2021	2.13B	126.32M	6.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error